A retrospective analysis of clinical outcomes between hospitalized patients with COVID‐19 who received famotidine or pantoprazole

DOI record: { "DOI": "10.1002/jgh3.12905", "ISSN": [ "2397-9070", "2397-9070" ], "URL": "http://dx.doi.org/10.1002/jgh3.12905", "alternative-id": [ "10.1002/jgh3.12905" ], "author": [ { "ORCID": "http://orcid.org/0000-0002-9519-4834", "affiliation": [ { "name": "Department of Medicine South Brooklyn Health Brooklyn New York USA" } ], "authenticated-orcid": false, "family": "Wagner", "given": "Justin J.", "sequence": "first" }, { "affiliation": [ { "name": "Department of Medicine South Brooklyn Health Brooklyn New York USA" } ], "family": "St. Cyr", "given": "Nikolas", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Medicine South Brooklyn Health Brooklyn New York USA" } ], "family": "Douen", "given": "Aaron", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Business Management Brooklyn New York USA" } ], "family": "Fogel", "given": "Joshua", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Medicine South Brooklyn Health Brooklyn New York USA" } ], "family": "Trillo", "given": "John", "sequence": "additional" } ], "container-title": "JGH Open", "container-title-short": "JGH Open", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2023, 7, 11 ] ], "date-time": "2023-07-11T04:44:46Z", "timestamp": 1689050686000 }, "deposited": { "date-parts": [ [ 2023, 7, 11 ] ], "date-time": "2023-07-11T04:45:09Z", "timestamp": 1689050709000 }, "indexed": { "date-parts": [ [ 2023, 7, 12 ] ], "date-time": "2023-07-12T04:27:09Z", "timestamp": 1689136029379 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2023, 7, 10 ] ] }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 7, 10 ] ], "date-time": "2023-07-10T00:00:00Z", "timestamp": 1688947200000 } } ], "link": [ { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12905", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "311", "original-title": [], "prefix": "10.1002", "published": { "date-parts": [ [ 2023, 7, 10 ] ] }, "published-online": { "date-parts": [ [ 2023, 7, 10 ] ] }, "publisher": "Wiley", "reference": [ { "key": "e_1_2_6_2_1", "unstructured": "World Health Organization. (2023).WHO Coronavirus Disease (COVID‐19) dashboard. Available from:https://covid19.who.int/Accessed 16 Jan 2023." }, { "article-title": "Clinical characteristics of COVID‐19 patients with digestive symptoms in Hubei, China", "author": "Pan L", "first-page": "1", "journal-title": "Am. J. Gastroenterol.", "key": "e_1_2_6_3_1", "volume": "115", "year": "2020" }, { "DOI": "10.1016/j.apsb.2020.02.008", "article-title": "Analysis of therapeutic targets for SARS‐CoV‐2 and discovery of potential drugs by computational methods", "author": "Wu C", "doi-asserted-by": "crossref", "first-page": "766", "journal-title": "Acta Pharm Sin. B.", "key": "e_1_2_6_4_1", "volume": "10", "year": "2020" }, { "article-title": "Mast cells contribute to coronavirus‐induced inflammation: new anti‐inflammatory strategy", "author": "Kritas SK", "first-page": "9", "journal-title": "J. Biol. Regul. Homeost. Agents", "key": "e_1_2_6_5_1", "volume": "34", "year": "2020" }, { "article-title": "Broad‐spectrum inhibition of coronavirus main and papain‐like proteases by HCV drugs", "author": "Anson BJ", "first-page": "10.21203/rs.3.r", "journal-title": "Res. Sq.", "key": "e_1_2_6_6_1", "year": "2020" }, { "DOI": "10.1126/science.abc4739", "doi-asserted-by": "crossref", "key": "e_1_2_6_7_1", "unstructured": "BorrellB.New York clinical trial quietly tests heartburn remedy against coronavirus. Available from:https://www.science.org/content/article/new-york-clinical-trial-quietly-tests-heartburn-remedy-against-coronavirus. Accessed 7 Nov 2021." }, { "DOI": "10.1053/j.gastro.2020.05.053", "article-title": "Famotidine use is associated with improved clinical outcomes in hospitalized COVID‐19 patients: a propensity score matched retrospective cohort study", "author": "Freedberg DE", "doi-asserted-by": "crossref", "first-page": "1129", "journal-title": "Gastroenterology", "key": "e_1_2_6_8_1", "volume": "159", "year": "2020" }, { "DOI": "10.14309/ajg.0000000000000832", "article-title": "Impact of famotidine use on clinical outcomes of hospitalized patients with COVID‐19", "author": "Mather JF", "doi-asserted-by": "crossref", "first-page": "1617", "journal-title": "Am. J. Gastroenterol.", "key": "e_1_2_6_9_1", "volume": "115", "year": "2020" }, { "article-title": "Association between famotidine use and COVID‐19 severity in Hong Kong: a territory‐wide study", "author": "Cheung KS", "first-page": "34940", "journal-title": "Gastroenterology", "key": "e_1_2_6_10_1", "volume": "0016", "year": "2020" }, { "DOI": "10.14309/ajg.0000000000001153", "article-title": "Comparative effectiveness of famotidine in hospitalized COVID‐19 patients", "author": "Shoaibi A", "doi-asserted-by": "crossref", "first-page": "692", "journal-title": "Am. J. Gastroenterol.", "key": "e_1_2_6_11_1", "volume": "116", "year": "2021" }, { "DOI": "10.1053/j.gastro.2020.10.011", "article-title": "Famotidine use is not associated with 30‐day mortality: a coarsened exact match study in 7158 hospitalized patients with coronavirus disease 2019 from a large healthcare system", "author": "Yeramaneni S", "doi-asserted-by": "crossref", "first-page": "919", "journal-title": "Gastroenterology", "key": "e_1_2_6_12_1", "volume": "160", "year": "2021" }, { "DOI": "10.1007/s10620-021-06872-z", "article-title": "Does famotidine reduce the risk of progression to severe disease, death, and intubation for COVID‐19 patients? A systemic review and meta‐analysis", "author": "Sun C", "doi-asserted-by": "crossref", "first-page": "3929", "journal-title": "Dig. Dis. Sci.", "key": "e_1_2_6_13_1", "volume": "66", "year": "2023" }, { "DOI": "10.1038/cddis.2016.218", "article-title": "Proton pump inhibitors protect mice from acute systemic inflammation and induce long‐term cross‐tolerance", "author": "Balza E", "doi-asserted-by": "crossref", "journal-title": "Cell Death Dis.", "key": "e_1_2_6_14_1", "volume": "7", "year": "2016" }, { "DOI": "10.1503/cmaj.092129", "article-title": "Use of acid‐suppressive drugs and risk of pneumonia: a systematic review and meta‐analysis", "author": "Eom CS", "doi-asserted-by": "crossref", "first-page": "310", "journal-title": "CMAJ", "key": "e_1_2_6_15_1", "volume": "183", "year": "2011" }, { "DOI": "10.1186/s12916-021-01907-8", "article-title": "Relation of severe COVID‐19 to polypharmacy and prescribing of psychotropic drugs: the REACT‐SCOT case‐control study", "author": "McKeigue PM", "doi-asserted-by": "crossref", "first-page": "51", "journal-title": "BMC Med.", "key": "e_1_2_6_16_1", "volume": "19", "year": "2021" }, { "DOI": "10.1097/MEG.0000000000002013", "article-title": "Pre‐hospitalization proton pump inhibitor use and clinical outcomes in COVID‐19", "author": "Ramachandran P", "doi-asserted-by": "crossref", "first-page": "137", "journal-title": "Eur. J. Gastroenterol. Hepatol.", "key": "e_1_2_6_17_1", "volume": "34", "year": "2022" }, { "article-title": "Severe clinical outcomes of COVID‐19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching", "author": "Lee SW", "first-page": "76", "journal-title": "Gut", "key": "e_1_2_6_18_1", "volume": "70", "year": "2020" }, { "DOI": "10.1111/joim.13183", "article-title": "Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis", "author": "Kow CS", "doi-asserted-by": "crossref", "first-page": "125", "journal-title": "J. Intern. Med.", "key": "e_1_2_6_19_1", "volume": "289", "year": "2021" }, { "DOI": "10.1136/gutjnl-2022-326952", "article-title": "Oral famotidine versus placebo in non‐hospitalised patients with COVID‐19: a randomised, double‐blind, data‐intense, phase 2 clinical trial", "author": "Brennan CM", "doi-asserted-by": "crossref", "first-page": "879", "journal-title": "Gut", "key": "e_1_2_6_20_1", "volume": "71", "year": "2022" }, { "DOI": "10.3389/fphar.2021.633680", "article-title": "COVID‐19: famotidine, histamine, mast cells, and mechanisms", "author": "Malone RW", "doi-asserted-by": "crossref", "journal-title": "Front. Pharmacol.", "key": "e_1_2_6_21_1", "volume": "12", "year": "2021" }, { "DOI": "10.1001/archinte.158.1.54", "article-title": "A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy", "author": "Lin HJ", "doi-asserted-by": "crossref", "first-page": "54", "journal-title": "Arch. Intern. Med.", "key": "e_1_2_6_22_1", "volume": "158", "year": "1998" }, { "DOI": "10.1136/bmj.38356.641134.8F", "article-title": "Systematic review and meta‐analysis of proton pump inhibitor therapy in peptic ulcer bleeding", "author": "Leontiadis GI", "doi-asserted-by": "crossref", "first-page": "568", "journal-title": "BMJ", "key": "e_1_2_6_23_1", "volume": "330", "year": "2005" }, { "DOI": "10.1016/j.transci.2020.102926", "article-title": "Anemia is associated with severe coronavirus disease 2019 (COVID‐19) infection", "author": "Hariyanto TI", "doi-asserted-by": "crossref", "journal-title": "Transfus. Apher. Sci.", "key": "e_1_2_6_24_1", "volume": "59", "year": "2020" }, { "DOI": "10.1001/jama.2019.22190", "article-title": "Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine‐2 receptor blockers on in‐hospital mortality among ICU patients receiving invasive mechanical ventilation", "author": "PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group", "doi-asserted-by": "crossref", "first-page": "616", "journal-title": "JAMA", "key": "e_1_2_6_25_1", "volume": "323", "year": "2020" }, { "DOI": "10.5414/CNP68065", "article-title": "Proton pump inhibitors and the kidney: critical review", "author": "Brewster UC", "doi-asserted-by": "crossref", "first-page": "65", "journal-title": "Clin. Nephrol.", "key": "e_1_2_6_26_1", "volume": "68", "year": "2007" }, { "DOI": "10.1159/000514940", "article-title": "Incidence and outcomes of acute kidney injury in COVID‐19: a systematic review", "author": "Raina R", "doi-asserted-by": "crossref", "first-page": "199", "journal-title": "Blood Purif.", "key": "e_1_2_6_27_1", "volume": "51", "year": "2022" }, { "DOI": "10.14309/01.ajg.0000715272.88349.c2", "article-title": "H2‐blocker use is associated with acute kidney injury among COVID‐19 patients", "author": "Trieu JA", "doi-asserted-by": "crossref", "first-page": "S1723", "journal-title": "Am. J. Gastroenter.", "key": "e_1_2_6_28_1", "volume": "115", "year": "2020" }, { "DOI": "10.1007/s00134-015-3725-1", "article-title": "Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients", "author": "Krag M", "doi-asserted-by": "crossref", "first-page": "833", "journal-title": "Intens. Care Med.", "key": "e_1_2_6_29_1", "volume": "41", "year": "2015" } ], "reference-count": 28, "references-count": 28, "relation": {}, "resource": { "primary": { "URL": "https://onlinelibrary.wiley.com/doi/10.1002/jgh3.12905" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Gastroenterology", "Hepatology" ], "subtitle": [], "title": "A retrospective analysis of clinical outcomes between hospitalized patients with <scp>COVID</scp>‐19 who received famotidine or pantoprazole", "type": "journal-article" }